ND
ENDRA Life Sciences Inc.
NDRA · NASDAQ
$5.93 -2.15% (-$0.13)
1M +1.72%
Market Cap $7.53M
P/E Ratio -
Div. Yield -
ROE 224.80%
Bulios Fair Price
$5.75
3.0% downside
Current Price
$5.93
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NDRA is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/B 1.19x
EV/EBITDA N/A
P/S N/A
Growth
0 /100
Declining Book val. growth 32.05%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 224.80%
ROA 74.50%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 7.10x
Debt/Equity 0.07x
Net debt/EBITDA N/A
Stability
35 /100
Moderate EPS volatility 50.47%
Profitable years 0
Beta -0.07x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NDRA
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Alexander Y. Tokman
Employees
10
Headquarters
Ann Arbor
Upcoming events
13 NOV
Earnings
Upcoming earnings report